CARA (Cara Therapeutics Inc) offers an objective long entry here on this pullback to the 6.70 support level with a suggested stop below 6.00 (or higher, if only targeting T1). The suggested beta-adjustment for the position size on this aggressive trade is 0.5 (i.e.- ½ of a typical swing position size).
The first target is 7.55 with the second & current final target the primary downtrend line. However, there is a good chance that CARA will ultimately go on to break above the downtrend line & morph into a longer-term trade/investment with additional price targets to be added. For those only targeting T1, a more aggressive stop should be considered.